Jeff Galvin
Jeff Galvin, the CEO and Founder of American Gene Technologies®, is a biotech pioneer who’s passionate about curing the world’s worst diseases with gene therapy.
He earned his BA degree in Economics from Harvard in 1981. Jeff has more than 30 years of business and entrepreneurial experience including founder or executive positions at a variety of Silicon Valley startups. Several of his companies were taken public and/or sold to public companies, including one in the medical-technology arena that was sold to Varian, the leading maker of linear accelerators used in cancer therapy.
Following his startup experience, Jeff retired to become an angel investor in real estate and high tech. He came out of retirement to found and fund American Gene™ after meeting National Institutes of Health (NIH) scientist Roscoe Brady, MD, PhD, who introduced him to cutting-edge viral vector technologies and gene therapies. Jeff quickly saw their potential and invested nearly everything he had to start American Gene and create the future he envisioned: a world without disease.
He earned his BA degree in Economics from Harvard in 1981. Jeff has more than 30 years of business and entrepreneurial experience including founder or executive positions at a variety of Silicon Valley startups. Several of his companies were taken public and/or sold to public companies, including one in the medical-technology arena that was sold to Varian, the leading maker of linear accelerators used in cancer therapy.
Following his startup experience, Jeff retired to become an angel investor in real estate and high tech. He came out of retirement to found and fund American Gene™ after meeting National Institutes of Health (NIH) scientist Roscoe Brady, MD, PhD, who introduced him to cutting-edge viral vector technologies and gene therapies. Jeff quickly saw their potential and invested nearly everything he had to start American Gene and create the future he envisioned: a world without disease.
